Abstract:Glucagon-like peptide-1 receptor (GLP-1R) agonists (GLP-1RAs) ameliorate mitochondrial health by increasing mitochondrial turnover in metabolically relevant tissues. Mitochondrial adaptation under metabolic stress is crucial to maintain pancreatic β-cell function and prevent type 2 diabetes (T2D) progression. While the GLP-1R is well known to stimulate cAMP production leading to Protein Kinase A (PKA) and Exchange Protein Activated by cyclic AMP 2 (Epac2) activation, there is a lack of understanding of the molecular mechanisms that link GLP-1RA-induced signalling with mitochondrial remodelling and functional adaptation. Here, we present a comprehensive study in β-cells and primary mouse and human islets that demonstrates that, following GLP-1RA stimulation, GLP-1R-positive endosomes associate with the endoplasmic reticulum (ER) membrane contact site (MCS) tether VAPB at ER-mitochondria MCSs (ERMCSs), where active GLP-1R engages with SPHKAP, an A-kinase anchoring protein (AKAP) linked to T2D and adiposity risk in genome-wide association studies (GWAS). The inter-organelle complex formed by endosomal GLP-1R, ER VAPB and SPHKAP triggers a pool of ERMCS-localised cAMP/PKA signalling which leads to the phosphorylation of the mitochondrial contact site and cristae organising system (MICOS) complex component MIC19 and is accompanied by mitochondrial remodelling and modulation of mitochondrial function, with important consequences for β-cell function and survival to oxidative stress.

What problem does this paper attempt to address?

The key problem that this paper attempts to solve is to reveal how the GLP - 1 receptor (GLP - 1R) regulates mitochondrial remodeling and function in pancreatic islet β - cells by interacting with membrane contact sites (MCSs) between the endoplasmic reticulum (ER) and mitochondria. Specifically, the study aims to clarify how the signaling pathways induced by GLP - 1R agonists (GLP - 1RAs) affect mitochondrial morphology and function, thereby improving the function and viability of β - cells, especially under metabolic stress conditions. ### Summary of main problems: 1. **GLP - 1R signaling mechanism**: - The research focuses on how GLP - 1R agonists (such as exendin - 4) activate GLP - 1R, leading to its binding to the VAPB protein on the endoplasmic reticulum membrane contact sites (ERMCSs). - Whether the binding of GLP - 1R - positive endosomes to ERMCSs requires the internalization of GLP - 1R, and how this binding affects downstream signaling. 2. **Regulation of mitochondrial remodeling and function**: - Explore how GLP - 1R signaling locally generates cAMP/PKA signaling through ERMCSs, and then phosphorylates MIC19, a component of the MICOS complex, affecting mitochondrial morphology and function. - Analyze the impact of these changes on β - cell function (such as insulin secretion) and the ability to cope with oxidative stress. 3. **Role of SPHKAP**: - Study how SPHKAP, as an A - kinase - anchoring protein (AKAP), localizes to ERMCSs through interaction with VAPB and participates in GLP - 1R signaling. - Evaluate the role of SPHKAP in GLP - 1R - dependent PKA signaling, especially its impact on mitochondrial function and β - cell function. ### Scientific significance: This study reveals the specific molecular mechanism by which GLP - 1R regulates mitochondrial morphology and function through interaction with ERMCSs. This not only helps to understand the mechanism of action of GLP - 1R agonists in the treatment of type 2 diabetes (T2D), obesity and other metabolic diseases, but also provides a theoretical basis for the development of new treatment strategies. ### Formula representation: The signaling pathways involved in the article can be represented by the following formulas: \[ \text{GLP - 1R} + \text{Agonist} \rightarrow \text{GLP - 1R}_{\text{internalized}} \] \[ \text{GLP - 1R}_{\text{internalized}} \rightarrow \text{VAPB} \text{ at ERMCSs} \] \[ \text{VAPB} + \text{SPHKAP} \rightarrow \text{cAMP/PKA signaling} \] \[ \text{cAMP/PKA signaling} \rightarrow \text{Phosphorylation of MIC19} \] \[ \text{Phosphorylation of MIC19} \rightarrow \text{Mitochondrial remodeling and function} \] These formulas show the process by which GLP - 1R agonists ultimately affect mitochondrial function through the interaction of GLP - 1R, VAPB and SPHKAP.

GLP-1R associates with VAPB and SPHKAP at ERMCSs to regulate β-cell mitochondrial remodelling and function

A Novel Angiogenesis Role of GLP-1(32-36) to Rescue Diabetic Ischemic Lower Limbs Via GLP-1R-Dependent Glycolysis

Acute changes in systemic glycemia gate access and action of GLP-1R agonist on brain structures controlling energy homeostasis

Liraglutide Prevents High Glucose Induced HUVECs Dysfunction Via Inhibition of PINK1/Parkin-dependent Mitophagy

The GLP-1 analog exendin-4 modulates HSP72 expression and ERK1/2 activity in BTC6 mouse pancreatic cells

The human batokine EPDR1 regulates β-cell metabolism and function

Stimulation of GLP-1 Receptor Inhibits Methylglyoxal-Induced Mitochondrial Dysfunctions in H9c2 Cardiomyoblasts: Potential Role of Epac/PI3K/Akt Pathway

1518-PUB: Role of PPARd in Regulating Autophagy Pathway in Improving Islet ß-Cell Function with GLP-1 Receptor Agonist

Targeting GLP-1 receptor trafficking to improve agonist efficacy

GLP-1 Receptor Signaling in Astrocytes Regulates Fatty Acid Oxidation, Mitochondrial Integrity, and Function

Cardiovascular Informatics: A Perspective on Promises and Challenges of IVUS Data Analysis

Agonist-induced membrane nanodomain clustering drives GLP-1 receptor responses in pancreatic beta cells

Glucagon-like peptide (GLP)-1 regulation of lipid and lipoprotein metabolism

Anaplastic large cell lymphoma in childhood.

The ghrelin gene products and exendin-4 promote survival of human pancreatic islet endothelial cells in hyperglycaemic conditions, through phosphoinositide 3-kinase/Akt, extracellular signal-related kinase (ERK)1/2 and cAMP/protein kinase A (PKA) signalling pathways

The association of cardiometabolic, diet and lifestyle parameters with plasma glucagon-like peptide-1: An IMI DIRECT study

Data Base Systems For Remote Sensing

GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects

Glucagon-Like Peptide 1 Protects against Hyperglycemic-Induced Endothelial-to-Mesenchymal Transition and Improves Myocardial Dysfunction by Suppressing Poly(ADP-Ribose) Polymerase 1 Activity

GLP-1-based therapies to boost autophagy in cardiometabolic patients: From experimental evidence to clinical trials

ER stress and unfolded protein response (UPR) signaling modulate GLP-1 receptor signaling in the pancreatic islets